Microbiological media and all chemical reagents were purchased from Oxoid, UK. Four hospital-acquired human pathogenic bacteria, namely, Acinetobacter baumannii (A. baumannii), Klebsiella pneumoniae (K. pneumoniae), Methicillin-resistant Staphylococcus aureus (MRSA), and Staphylococcus aureus (S. aureus), were collected from a clinical setting in Cairo, Egypt. They were identified as multidrug-resistant bacteria.
The adult human dermal fibroblast (HDFa) cell line (PCS-201-012, HDFa) was purchased from the American Type Culture Collection (ATCC). The EMEM medium, fetal bovine serum (FBS), non-essential amino acids (NEAAs), penicillin, and streptomycin were supplied by Thermo Fisher (Hessen, Germany). The MTT reagent was supplied by Thermo Fisher, Germany. All other materials were purchased from Sigma-Aldrich and used as supplied.